Budget 2026-27 launches Biopharma SHAKTI, ISM 2.0, Rare Earth Corridors and container scheme
The Union Budget 2026-27, presented on 1 February 2026, announced Biopharma SHAKTI with ₹10,000 crore over five years, India Semiconductor Mission 2.0, dedicated Rare Earth Corridors in four states and a ₹10,000 crore container manufacturing scheme.
Summary
The Union Budget 2026-27, presented on 1 February 2026, set out a push to scale up manufacturing in seven strategic and frontier sectors. Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation) gets ₹10,000 crore over five years, with three new NIPERs, seven upgraded NIPERs and over 1,000 accredited clinical trial sites. India Semiconductor Mission 2.0 will focus on equipment, materials, full-stack Indian IP and supply chains, and the Electronics Components Manufacturing Scheme outlay rises to ₹40,000 crore. Dedicated Rare Earth Corridors will support Odisha, Kerala, Andhra Pradesh and Tamil Nadu. A scheme will help states set up three chemical parks through a challenge route, and a container manufacturing scheme gets over ₹10,000 crore over five years.
Key facts
- Biopharma SHAKTI
- ₹10,000 crore over 5 years; 3 new NIPERs, 7 upgraded; 1,000+ clinical trial sites
- ISM 2.0
- Equipment, materials, full-stack Indian IP, supply chains
- ECMS outlay
- Raised to ₹40,000 crore
- Rare Earth Corridors
- Odisha, Kerala, Andhra Pradesh, Tamil Nadu
- Chemical parks
- 3, via challenge route
- Container manufacturing
- Over ₹10,000 crore over 5 years
Practice MCQs 4 questions
What outlay did the Union Budget 2026-27 announce for Biopharma SHAKTI?
Show answer
Correct answer: D — ₹10,000 crore over 5 years
Biopharma SHAKTI has an outlay of ₹10,000 crore over the next five years.
Which of the following states is NOT among those to be supported by the dedicated Rare Earth Corridors announced in the Union Budget 2026-27?
Show answer
Correct answer: A — Jharkhand
The Rare Earth Corridors will support Odisha, Kerala, Andhra Pradesh and Tamil Nadu.
To what amount did the Union Budget 2026-27 raise the outlay of the Electronics Components Manufacturing Scheme?
Show answer
Correct answer: B — ₹40,000 crore
The Electronics Components Manufacturing Scheme outlay was increased to ₹40,000 crore.
Consider the following about Biopharma SHAKTI, announced in the Union Budget 2026-27: 1. It includes creating three new National Institutes of Pharmaceutical Education and Research and upgrading seven existing ones. 2. It plans a network of over 1,000 accredited India Clinical Trials sites. Which of the above is/are correct?
Show answer
Correct answer: C — Both 1 and 2
Both are correct.